TEMIS has been acquired by Expert System
The private shareholders of TEMIS have sold the company to Expert System for US$15 million. Expert System and TEMIS join forces to create a leading semantic technology provider for cognitive computing.
TEMIS helps organizations structure, manage and leverage their unstructured information assets. Its flagship platform Luxid® identifies and extracts targeted information to semantically enrich content with domain-specific metadata. Luxid® enables professional publishers to efficiently package and deliver relevant information to their audience, and helps enterprises to intelligently archive, manage, analyze, discover and share increasing volumes of information. Founded in 2000, TEMIS operates in the United States, Canada, UK, France and Germany, and is represented worldwide through its network of certified partners.
Expert System is focused on the intersection of technology and language. The company's patented Cogito platform has transformed how technology understands written content and communication, dramatically improving the ability to use all information available for market intelligence, decision making and strategic planning. Expert System provides an ever-increasing number of applications in multiple languages to many of the largest and most admired companies and government agencies throughout Europe, the Americas and Middle East.
Oaklins' team in France advised the seller in this transaction.
Talk to the deal team
Related deals
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn moreMicrofinanciera Fundeser has been sold to Grupo Financiero Atlántida
Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.
Learn more